Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can tamoxifen or anastrozole prevent bicalutamide-induced gynecomastia and breast pain in prostate cancer?

Nature Clinical Practice Urology volume 2, pages 276–277 (2005)Cite this article

boxed-textBoccardo F et al. (2005) Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol 23: 808–815

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wirth MP et al. (2004) Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. J Urol 172: 1865–1870

    Article  CAS  Google Scholar 

  2. Messing EM et al. (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341: 1781–1788

    Article  CAS  Google Scholar 

  3. Bolla M et al. (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360: 103–106

    Article  CAS  Google Scholar 

  4. Sieber PR et al. (2004) Bicalutamide 150 mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer. J Urol 171: 2272–2276

    Article  CAS  Google Scholar 

  5. Saltzstein D et al. (2002) Prophylactic tamoxifen significantly reduces the incidence of bicalutamide-induced gynecomastia and breast pain. BJU Int 90 (Suppl 2): 120–121

    Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Medical Director at the Urological Associates of Lancaster, Lancaster, PA, USA

    Paul Sieber

Authors
  1. Paul Sieber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Sieber.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

GYNECOMASTIA

Excessive development of male mammary glands, usually caused by excess estrogens, testosterone deficiency, or hyperprolactinemia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sieber, P. Can tamoxifen or anastrozole prevent bicalutamide-induced gynecomastia and breast pain in prostate cancer?. Nat Rev Urol 2, 276–277 (2005). https://doi.org/10.1038/ncpuro0206

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0206

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing